Latest Health News

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

Alpha HPA Limited has reached a major funding milestone with a $400 million senior debt package for its HPA First Project Stage 2, while experiencing accelerating demand from the semiconductor sector and advancing new product developments.

Bio-Gene Technology Limited has been awarded two U.S. Department of Defense grants totaling A$3 million to develop innovative insect control products targeting military and civilian markets.

BCI Minerals reports robust progress in its Mardie Salt and Potash Project, achieving financial close on a $981 million debt facility and advancing construction beyond the halfway mark. The company maintains a strong focus on sustainability and safety as it targets first salt shipment in Q2 FY27.

Holista Colltech Limited reports a notable financial recovery in 4QFY24, underpinned by strong cash inflows and a rebound in its Food Ingredients division, alongside a leadership change aimed at steering future growth.

Actinogen Medical accelerates recruitment in its pivotal XanaMIA Alzheimer's trial while securing a strong cash position of $22.9 million, underpinning its late-stage development and commercial readiness.

Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.

Aroa Biosurgery has reported its first quarter of positive operating cash flow since listing on the ASX in 2020, alongside robust revenue growth projections and new regulatory approvals across key international markets.

4DMedical reports a remarkable 202% increase in Q2 FY2025 operating revenue, driven by rapid site expansion and key collaborations with leading healthcare providers and the U.S. Department of Defense.

Mitchell Services reported a $46.7 million revenue and $5.6 million EBITDA in Q2 FY25, reflecting a strategic transition phase marked by increased mobilisation for new projects in PNG and decarbonisation drilling. Despite short-term softness, the company’s strengthened balance sheet and expanded service offerings position it for growth.

Meeka Metals has made substantial strides in developing its Murchison Gold Project, backed by a fully funded expansion and a robust feasibility study projecting $1 billion in pre-tax free cash flow over 10 years. With first gold targeted for mid-2025, infrastructure and mining operations are advancing ahead of schedule.

Bulletin Resources continues its appeal against the refusal of a Native Vegetation Clearing Permit critical to advancing drilling at its Ravensthorpe Lithium Project, while maintaining a strong cash position and reviewing strategic opportunities.